Literature DB >> 12127135

Effect of duodenal diversion on low-grade dysplasia in patients with Barrett's esophagus: analysis of 37 patients.

Attila Csendes1, Gladys Smok, Patricio Burdiles, Italo Braghetto, Cesar Castro, Owen Korn.   

Abstract

It is well known that in patients with Barrett's esophagus (BE), even after antireflux surgery, intestinal metaplasia can progress to dysplasia or even adenocarcinoma. However, the opposite-that is regression of dysplastic changes to intestinal metaplasia after antireflux surgery-has been documented in only a few reports. The objective of this study was to determine the effect of a duodenal diversion operation on low-grade dysplasia in patients with BE. Thirty-seven patients with either short-segment (n = 12) or long-segment (n = 25) BE underwent antireflux surgery plus either a duodenal switch procedure (13 patients) or a partial distal gastrectomy with Roux-en-Y gastrojejunal anastomosis (24 patients). All of them were subjected to complete clinical, endoscopic, histologic, manometric, and 24-hour pH testing, and 24-hour monitoring of the bile exposure in distal esophagus. There were no deaths in this series, and morbidity occurred in only one patient (2.7%). Manometric assessment after surgery showed a significant increase in sphincter pressure, abdominal length, and total length (P < 0.001). Acid reflux showed a significant decrease after surgery, and duodenal reflux was completely abolished in all except one patient. Follow-up in all patients was longer than 24 months (mean 60 months). Three to four endoscopic procedures were performed after surgery in each patient, and several biopsy specimens were taken distal to the squamo-columnar junction during each endoscopic procedure. Eleven patients (91%) with short-segment BE demonstrated histologic regression to either cardiac mucosa or nondysplastic intestinal metaplasia. Among the 25 patients with long-segment BE, there was a 62.5% rate of histologic regression to nondysplastic epithelium when the length of BE measured between 31 and 99 mm and 33% histologic regression when the length of BE was 101 mm or more. There were no cases of progression to high-grade dysplasia or adenocarcinoma. The endoscopic length of the columnar-lined esophagus did not change late after surgery. In 65% of patients with BE, antireflux surgery, gastric acid reduction, and duodenal diversion produced histologic regression of low-grade dysplasia to nondysplastic mucosa. This effect was even more pronounced when the length of BE was shorter. It seems to be permanent, and no progression to high-grade dysplasia or adenocarcinoma has occurred.

Entities:  

Mesh:

Year:  2002        PMID: 12127135     DOI: 10.1016/s1091-255x(02)00007-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  27 in total

1.  Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats.

Authors:  S E Attwood; T C Smyrk; T R DeMeester; S S Mirvish; H J Stein; R A Hinder
Journal:  Surgery       Date:  1992-05       Impact factor: 3.982

2.  Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation.

Authors:  A Csendes; I Braghetto; P Burdiles; G Puente; O Korn; J C Díaz; F Maluenda
Journal:  Surgery       Date:  1998-06       Impact factor: 3.982

3.  Location of the lower oesophageal sphincter and the squamous columnar mucosal junction in 109 healthy controls and 778 patients with different degrees of endoscopic oesophagitis.

Authors:  A Csendes; F Maluenda; I Braghetto; P Csendes; A Henriquez; M S Quesada
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

4.  Barrett's esophagus. A surgical entity.

Authors:  V A Starnes; R B Adkins; J F Ballinger; J L Sawyers
Journal:  Arch Surg       Date:  1984-05

5.  Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.

Authors:  H J Stein; W K Kauer; H Feussner; J R Siewert
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

6.  Barrett's esophagus. Comparison of benign and malignant cases.

Authors:  D B Skinner; B C Walther; R H Riddell; H Schmidt; C Iascone; T R DeMeester
Journal:  Ann Surg       Date:  1983-10       Impact factor: 12.969

7.  Technique, indications, and clinical use of 24 hour esophageal pH monitoring.

Authors:  T R DeMeester; C I Wang; J A Wernly; C A Pellegrini; A G Little; P Klementschitsch; G Bermudez; L F Johnson; D B Skinner
Journal:  J Thorac Cardiovasc Surg       Date:  1980-05       Impact factor: 5.209

8.  Barrett's oesophagus: effect of antireflux surgery on symptom control and development of complications.

Authors:  S E Attwood; A P Barlow; T L Norris; A Watson
Journal:  Br J Surg       Date:  1992-10       Impact factor: 6.939

9.  Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin.

Authors:  W K Kauer; P Burdiles; A P Ireland; G W Clark; J H Peters; C G Bremner; T R DeMeester
Journal:  Am J Surg       Date:  1995-01       Impact factor: 2.565

10.  Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus.

Authors:  S E Attwood; T R DeMeester; C G Bremner; A P Barlow; R A Hinder
Journal:  Surgery       Date:  1989-10       Impact factor: 3.982

View more
  6 in total

1.  Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett's esophagus: a prospective study.

Authors:  Italo Braghetto; Owen Korn; Attila Csendes; Luis Gutiérrez; Héctor Valladares; Max Chacon
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

2.  Effect of gastric bypass on Barrett's esophagus and intestinal metaplasia of the cardia in patients with morbid obesity.

Authors:  Attila Csendes; Ana Maria Burgos; Gladys Smok; Patricio Burdiles; Ana Henriquez
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

Review 3.  Adenocarcinoma appearing very late after antireflux surgery for Barrett's esophagus: long-term follow-up, review of the literature, and addition of six patients.

Authors:  Attila Csendes; Patricio Burdiles; Italo Braghetto; Owen Korn
Journal:  J Gastrointest Surg       Date:  2004 May-Jun       Impact factor: 3.452

Review 4.  Surgical treatment of Barrett's esophagus: 1980-2003.

Authors:  Attila Csendes
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

5.  Esophageal carcinoma following bariatric procedures.

Authors:  Jeff W Allen; Matthew F Leeman; J David Richardson
Journal:  JSLS       Date:  2004 Oct-Dec       Impact factor: 2.172

6.  Does Bile Reflux Influence the Progression of Barrett's Esophagus to Adenocarcinoma? (Gastroenterology 2013;145:1300-1311).

Authors:  Tatsuhiro Masaoka; Hidekazu Suzuki
Journal:  J Neurogastroenterol Motil       Date:  2013-12-30       Impact factor: 4.924

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.